Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cardio-Pulmonary Exercise Testing - Patient Information].

Pneumologie (Stuttgart, Germany)·2026
Same author

Practical guide to cardiopulmonary exercise testing in adults.

Respiratory research·2022
Same author

[Specialist examination: Is the current format still up-to-date?]

Deutsche medizinische Wochenschrift (1946)·2021
Same author

Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease.

Lung·2021
Same author

Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.

Respiratory medicine·2016
Same author

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

International journal of chronic obstructive pulmonary disease·2016

Related Experiment Video

Updated: Jun 6, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.

Heike Rau-Berger1, Harald Mitfessel, Thomas Glaab

  • 1Medical Affairs Germany, Respiratory Medicine, Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany.

International Journal of Chronic Obstructive Pulmonary Disease
|November 25, 2010
PubMed
Summary

Tiotropium Respimat improved physical functioning in chronic obstructive pulmonary disease (COPD) patients within six weeks. This real-world study found improvements regardless of smoking status, with good tolerability.

Keywords:
COPDphysical functiontherapytiotropium

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Related Experiment Videos

Last Updated: Jun 6, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) significantly impacts physical functioning.
  • Effective management of COPD symptoms is crucial for improving patients' quality of life.

Purpose of the Study:

  • To evaluate the real-world effectiveness of tiotropium Respimat® on physical functioning in COPD patients.
  • To assess the tolerability of tiotropium Respimat® in a daily practice setting.

Main Methods:

  • An open-label, observational study involving 1,230 COPD patients.
  • Patients received tiotropium 5 μg once daily via Respimat® Soft Inhaler for 6 weeks.
  • Physical functioning was assessed using the Physical Function subdomain (PF-10) of the SF-36 questionnaire at baseline and week 6.

Main Results:

  • 61.5% of patients achieved a ≥10-point improvement in standardized PF-10 scores.
  • Mean PF-10 scores improved significantly (P < 0.001) by 13.4 points.
  • Adverse events were reported by 4.0% of patients, primarily respiratory symptoms and dry mouth.

Conclusions:

  • Tiotropium Respimat® rapidly improved physical function in COPD patients within 6 weeks of treatment in a real-life setting.
  • The benefits on physical function were observed irrespective of patients' smoking status.
  • The treatment demonstrated good tolerability in the studied COPD population.